Anixa Biosciences (CY71) Stock Forecast & Price Target
3 Followers
CY71 Analyst Ratings
Moderate Buy
2Buy0Hold0Sell
Based on 2 analysts giving stock ratings to Anixa Biosciences in the past 3 months
CY71 Stock 12 Month Forecast
Average Price Target
EUR 8.94▲(224.54% Upside)Based on 2 Wall Street analysts offering 12 month price targets for Anixa Biosciences in the last 3 months. The average price target is EUR 8.94 with a high forecast of EUR 12.52 and a low forecast of EUR 5.36. The average price target represents a 224.54% change from the last price of EUR 2.76.
Past 12 Months12 Month ForecastJan2026Oct2026
HighEUR 12.52
AverageEUR 8.94
LowEUR 5.36
Highest Price TargetHighestEUR 12.52Average Price TargetEUR 8.94Lowest Price TargetLowestEUR 5.36
Detailed List of Analyst Forecasts
Analyst Type
Ranks
Analyst Rating
Upside/ Downside
Action
| Price Target | Follow | Article | ||||||
|---|---|---|---|---|---|---|---|---|
| Yi Chen | H.C. Wainwright | EUR 5.36 | buy | 94.72%Upside | Reiterated | 10/27/26 | ||
| Jason McCarthy | Maxim Group | EUR 12.52 | buy | 354.36%Upside | Reiterated | 10/26/26 | ||
| Patrick McCann, CFA | D. Boral Capital | EUR 8.94 | buy | 224.54%Upside | Initiated | 06/30/26 |
| Rating | Follow | Article | |||
|---|---|---|---|---|---|
| Yi ChenH.C. Wainwright | BuyReiteratedEUR 5.36 | 10/27/26 | 94.72%Upside | ||
| Jason McCarthyMaxim Group | BuyReiteratedEUR 12.52 | 10/26/26 | 354.36%Upside | ||
| Patrick McCann, CFAD. Boral Capital | BuyInitiatedEUR 8.94 | 06/30/26 | 224.54%Upside |
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
Best Analysts Covering Anixa Biosciences
3 Months
Success Rate10/16 ratings generated profit
63%
Average Return
+4.94%
Copying Yi Chen's trades and holding each position for 3 Months would result in 62.50% of your transactions generating a profit, with an average return of +4.94% per trade.
1 Year
Success Rate8/16 ratings generated profit
50%
Average Return
+3.10%
Copying Yi Chen's trades and holding each position for 1 Year would result in 50.00% of your transactions generating a profit, with an average return of +3.10% per trade.
2 Years
Success Rate6/16 ratings generated profit
38%
Average Return
-3.28%
Copying Yi Chen's trades and holding each position for 2 Years would result in 37.50% of your transactions generating a profit, with an average return of -3.28% per trade.
CY71 Analyst Recommendation Trends
| Rating | Jun 26 | Jul 26 | Aug 26 | Sep 26 | Oct 26 |
|---|---|---|---|---|---|
| Strong Buy | 3 | 2 | 1 | 4 | 4 |
| Buy | 0 | 0 | 0 | 0 | 0 |
| Hold | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 |
| total | 3 | 2 | 1 | 4 | 4 |
In the current month, CY71 has received 4 Buy Ratings, 0 Hold Ratings, and 0 Sell Ratings. CY71 average Analyst price target in the past 3 months is 8.94.
CY71 Financial Forecast
CY71 Stock Forecast FAQ
What is DE:CY71’s average 12-month price target, according to analysts?
Based on analyst ratings, Anixa Biosciences’s 12-month average price target is €8.94.
What is DE:CY71’s upside potential, based on the analysts’ average price target?
Anixa Biosciences has 224.54% upside potential, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is Anixa Biosciences a Buy, Sell or Hold?
Anixa Biosciences has a consensus rating of Moderate Buy, which is based on 2 buy ratings, 0 hold ratings and 0 sell ratings.
What is Anixa Biosciences’s share price target?
The average share price target for Anixa Biosciences is €8.94. This is based on 2 Wall Street analysts’ 12-month price targets, issued in the past 3 months. The highest analyst share price target is €12.52, and the lowest forecast is €5.36. The average share price target represents a 224.54% increase from the current price of €2.755.
What do analysts say about Anixa Biosciences?
Anixa Biosciences’s analyst rating consensus is a Moderate Buy. This is based on the ratings of 2 Wall Street analysts.
How can I buy shares of Anixa Biosciences?
To buy shares of DE:CY71, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.
